Search research articles
Contact Us
Filters
Showing results (311-320 of 352) with videos related to
Page
of 36
Sort By:
Gastroenterology
|
August 20, 2013
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC
Marc Ferrante, Jean-Frederic Colombel, William J Sandborn, et al.
Journal of Crohn'S & Colitis
|
November 24, 2020
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
Manasi Agrawal, Erica J Brenner, Xian Zhang, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2024
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
Séverine Vermeire, Stefan Schreiber, David T Rubin, et al.
The Lancet. Gastroenterology & Hepatology
|
July 9, 2023
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
Tommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, et al.
Frontiers in Immunology
|
May 31, 2022
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease
Angelika Wagner, Erika Garner-Spitzer, Anna-Margarita Schötta, et al.
Lancet (London, England)
|
May 22, 2017
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
Séverine Vermeire, William J Sandborn, Silvio Danese, et al.
Gastroenterology
|
July 8, 2018
Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis
Shannon E Telesco, Carrie Brodmerkel, Hongyan Zhang, et al.
Gastroenterology
|
December 28, 2020
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner, Amanda Ricciuto, Ayanna Lewis, et al.
Gastroenterology
|
December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Julián Panés, Damián García-Olmo, Gert Van Assche, et al.
Inflammatory Bowel Diseases
|
March 26, 2011
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study
Mats Sjöberg, Andrea Walch, Mina Meshkat, et al.
Page
of 36
Search research articles
Search
Showing results (311-320 of 352) with videos related to
Sort By:
Page
of 36
Gastroenterology
|
August 20, 2013
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC
Marc Ferrante, Jean-Frederic Colombel, William J Sandborn, et al.
Journal of Crohn'S & Colitis
|
November 24, 2020
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
Manasi Agrawal, Erica J Brenner, Xian Zhang, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2024
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
Séverine Vermeire, Stefan Schreiber, David T Rubin, et al.
The Lancet. Gastroenterology & Hepatology
|
July 9, 2023
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
Tommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, et al.
Frontiers in Immunology
|
May 31, 2022
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease
Angelika Wagner, Erika Garner-Spitzer, Anna-Margarita Schötta, et al.
Lancet (London, England)
|
May 22, 2017
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
Séverine Vermeire, William J Sandborn, Silvio Danese, et al.
Gastroenterology
|
July 8, 2018
Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis
Shannon E Telesco, Carrie Brodmerkel, Hongyan Zhang, et al.
Gastroenterology
|
December 28, 2020
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner, Amanda Ricciuto, Ayanna Lewis, et al.
Gastroenterology
|
December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Julián Panés, Damián García-Olmo, Gert Van Assche, et al.
Inflammatory Bowel Diseases
|
March 26, 2011
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study
Mats Sjöberg, Andrea Walch, Mina Meshkat, et al.
Page
of 36